Quality Regulations: Unterschied zwischen den Versionen

Aus cannabis.gmpvintern.de
Zur Navigation springen Zur Suche springen
(Die Seite wurde neu angelegt: „== Scope == == Regulations for Cultivation & Collection == WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Li…“)
 
 
(3 dazwischenliegende Versionen von 2 Benutzern werden nicht angezeigt)
Zeile 4: Zeile 4:
  
 
WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Link to WHO)
 
WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Link to WHO)
 +
 +
[https://apps.who.int/iris/bitstream/handle/10665/42783/9241546271.pdf;sequence=1 WHO GACP Guideline]
  
 
== Regulations for Processing, Packaging and Storage ==
 
== Regulations for Processing, Packaging and Storage ==
Zeile 9: Zeile 11:
 
=== Requirements Health Canada ===
 
=== Requirements Health Canada ===
 
Health Canada's Cannabis Regulations SOR/2018-144 requires surveillance of the premises in section 64-66.
 
Health Canada's Cannabis Regulations SOR/2018-144 requires surveillance of the premises in section 64-66.
 +
 +
[https://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-144/ HC Cannabis Regulations]
 
   
 
   
−
GAP Canada Version (current Version 8.0 – April 1, 2020)
+
GAP Canada Version (current Version 9.0 – April 1, 2021)
 
A revision is usually done in February each year.
 
A revision is usually done in February each year.
 +
 +
[https://www.canadagap.ca/2021/03/canadagap-program-changes-for-2021-and-release-of-version-9-0-of-the-program-management-manual/ GAP Canada V 9.0]
 
   
 
   
−
Health Canada; Good Manufacturing Practices (GUI-0001); October 1, 2018
+
Health Canada; Good Manufacturing Practices (GUI-0001); July 1, 2020
 +
 
 +
[https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-0001/document.html HC GMP 2020]
 
   
 
   
 
=== European Union ===
 
=== European Union ===
 
Reflection paper on microbiological aspects of herbal medicinal products and traditional herbal medicinal products
 
Reflection paper on microbiological aspects of herbal medicinal products and traditional herbal medicinal products
−
https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-microbiological-aspects-herbal-medicinal-products-traditional-herbal-medicinal_en.pdf
+
 
 +
[https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-microbiological-aspects-herbal-medicinal-products-traditional-herbal-medicinal_en.pdf EMA Reflection paper]
 
   
 
   
 
== Application requirements for cannabis cultivation, processing and medical sales licences ==
 
== Application requirements for cannabis cultivation, processing and medical sales licences ==
Zeile 23: Zeile 32:
 
=== Requirements Health Canada ===
 
=== Requirements Health Canada ===
 
Application requirements for cannabis cultivation, processing and medical sales licences
 
Application requirements for cannabis cultivation, processing and medical sales licences
 +
 +
== United Kingdom (UK) ==
 +
MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020
 +
 +
[https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials MHRA Guidance] (website)
 +
 +
[https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/869284/Cannabis_Guidance__unlicensed_CBPMs__updated_2020.pdf The supply of unlicensed cannabis-based products for medicinal use in humans], 2020 (document)
 +
 +
[https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/373505/The_supply_of_unlicensed_medicinal_products__specials_.pdf The supply of unlicensed medicinal products 'specials", MHRA Guidance Note 14], 2014 (document)

Aktuelle Version vom 18. Oktober 2021, 14:07 Uhr

Scope[Bearbeiten]

Regulations for Cultivation & Collection[Bearbeiten]

WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Link to WHO)

WHO GACP Guideline

Regulations for Processing, Packaging and Storage[Bearbeiten]

Requirements Health Canada[Bearbeiten]

Health Canada's Cannabis Regulations SOR/2018-144 requires surveillance of the premises in section 64-66.

HC Cannabis Regulations

GAP Canada Version (current Version 9.0 – April 1, 2021) A revision is usually done in February each year.

GAP Canada V 9.0

Health Canada; Good Manufacturing Practices (GUI-0001); July 1, 2020

HC GMP 2020

European Union[Bearbeiten]

Reflection paper on microbiological aspects of herbal medicinal products and traditional herbal medicinal products

EMA Reflection paper

Application requirements for cannabis cultivation, processing and medical sales licences[Bearbeiten]

Requirements Health Canada[Bearbeiten]

Application requirements for cannabis cultivation, processing and medical sales licences

United Kingdom (UK)[Bearbeiten]

MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020

MHRA Guidance (website)

The supply of unlicensed cannabis-based products for medicinal use in humans, 2020 (document)

The supply of unlicensed medicinal products 'specials", MHRA Guidance Note 14, 2014 (document)